Articles published by VIVAZEN

VIVAZEN® Launches Safe Shelves Initiative to Help Protect Consumers and Retailers from Illegal 7-OH and Other Synthetic Drugs

August 05, 2026

From VIVAZEN

Via Business Wire

VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs

July 01, 2026

From VIVAZEN

Via Business Wire

VIVAZEN® Urges Immediate Action on 7-OH as U.S. House of Representatives Examines End Needless Distribution of 7-OH Act

March 27, 2026

From VIVAZEN

Via Business Wire

Groundbreaking Clinical Study Reveals Promising Evidence for VIVAZEN®’s Kratom Extracts

February 19, 2026

From VIVAZEN

Via Business Wire

VIVAZEN® Applauds Kentucky’s Leadership in Protecting Consumers from Synthetic 7-Hydroxymitragynine (7-OH)

November 06, 2025

From VIVAZEN

Via Business Wire

Vivazen® Reports Positive Results from Stress Relief Real-World Study*

September 09, 2025

From Vivazen

Via Business Wire

VIVAZEN® Applauds Florida’s Emergency Ban on Synthetic 7-OH, Reinforces Commitment to Safe, Natural Kratom

August 14, 2025

From VIVAZEN

Via Business Wire

VIVAZEN® and MoreBetter® Announce Landmark Real-World Evidence Study on Its Proprietary Extract, Highlighting the Power of Botanicals in Daily Wellness

August 13, 2025

From VIVAZEN

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.